Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The ESC Working Group on Cardiovascular Pharmacotherapy has developped an engaging and interactive educational programme to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials. Please find below resources from October 2016 Course and Workshop held in conjunction with EuroThrombosis Meeting, London, UK. This programme is supported by an unrestricted educational grant from Amgen & Daiichi Sankyo.
Sven Wassmann, MD, PhD, FESC
Giuseppe MC Rosano, MD, PhD, FESC
An overview of the different aspects of clinical trials - Niessner
Traditional versus novel trial designing - G.M.C. Rosano
The objectives, the site, the finance and the role of the ethics committee and research organization - B.S. Lewis
Requirements from regulatory agencies: endpoints, comparators, type of studies - G.M.C. Rosanor
Post marketing surveillance - Walther
The role of the principal investigator: keys to success, perils and tribulations - B.S. Lewis
The team, the procedures, the monitor and the sponsor - B.S. Lewis
Randomised controlled trials - Niessner
Observational trials and registries - G.L. Savarese
Meta-analyses and systematic reviews - G.L. Savarese
GCP for the busy investigator (certificate included) -D. Rolfe
Examples from recent clinical trials - Wassmann, Panelists
Certificates and closing remarks - B.S. Lewis, S. Wassmann
This course was supported in the form of an unrestricted educationa grant by Amgen and Daiichhi Sankyo
© 2017 European Society of Cardiology. All rights reserved